Ma G

ORCID: 0000-0002-6464-7167 · 6 papers in corpus
2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1540557

ObjectiveA growing number of research papers have looked at the influence of exercise on pain severity in people with primary dysmenorrhea, but the findings have been inconsistent. The purpose of this research was to thoroughly evaluate the…

2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1516473

The unique physiological structure of women has led to a variety of diseases that have attracted the attention of many people in recent years. Disturbances in the reproductive system microenvironment lead to the progression of various femal…

2021
Gland surgery ·doi:10.21037/gs-21-400

ObjectiveOur purpose is to explain the onset, diagnosis, and treatment of pancreatic tumor-associated pancreatitis (PTP), and inform clinicians about the management of PTP. It is hoped that clinicians can gain some experience and inspiratio…

2020
Cancer medicine ·doi:10.1002/cam4.3098

IntroductionIntravenous leiomyomatosis (IVL) is currently regarded as a special variant of the common uterine leiomyoma (LM). Though IVL shows a similar histological morphology to LM, IVL is characterized by unique intravenous growth patter…

article 2016
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences ·doi:10.1016/j.ejps.2016.10.031

Our study investigated poly(lactic-co-glycolic acid) (PLGA) as protein delivery vehicles encapsulate CTLA-4-antibody (anti-CTLA-4) which is essential for CD4+CD25+Treg cells suppressive function exposing superior potential for inhibiting en…

article 2010
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences ·doi:10.1016/j.ejps.2010.01.012

The objective of this study was to prepare a novel mifepristone-loaded PCL/Pluronic F68 implant to achieve long-term treatment of endometriosis. PCL/Pluronic F68 compound (90/10, w/w) with viscosity average molecular weight of 65,000 was su…